1180495-75-3

Usage

Contains

Amino group, chloro group, and methoxy group attached to the benzene ring

Potential applications

Building block in pharmaceutical synthesis, intermediate in organic and medicinal chemistry

Caution

Handle and use with care, may present hazards if not handled properly

Upstream product

• 1180495-72-0 N-(2-chloro-3-methoxyphenyl)-2-hydroxyiminoacetamide 
• 1180495-73-1 7-chloro-6-methoxy-1H-indole-2,3-dione 
• 85893-87-4 2-chloro-3-methoxyaniline hydrochloride 
• 1180495-74-2 2-amino-3-chloro-4-methoxy benzoic acid 
• 74-88-4 methyl iodide 
• 77-92-9 citric acid 

Downstream Products

• 1180495-76-4 methyl 3-chloro-2-(4-isopropylthiazole-2-carboxamido)-4-methoxybenzoate 

Relevant academic research and scientific papers

Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, and pharmaceutical compositions and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

MACROCYCLIC SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING HCV INFECTIONS

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, and pharmaceutical compositions and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula (Ia) or (Ib), pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

MACROCYCLIC SERINE PROTEASE INHIBITORS

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

MACROCYCLIC SERINE PROTEASE INHIBITORS

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof